Interpretation of a 5/10 Score on a Borderline Personality Questionnaire
A score of 5 out of 10 on a borderline personality disorder screening questionnaire falls below the diagnostic threshold and does not indicate BPD, but it does suggest the presence of clinically significant borderline features that warrant further clinical evaluation and monitoring.
Understanding the Score
The most validated BPD screening instrument is the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD), which uses a 10-item format. For the MSI-BPD, a cutoff score of 7 or more items is required to screen positive for BPD, with this threshold yielding 81% sensitivity and 85% specificity 1. Your patient's score of 5/10 falls in the subthreshold range—below the diagnostic screening threshold but above zero.
Clinical Significance of Subthreshold Scores
Research demonstrates that dimensional scoring of borderline features is particularly important at subthreshold levels. Studies show that even patients with just 1 borderline criterion have significantly more psychosocial morbidity than those with 0 criteria 2. The correlation between number of borderline features and illness severity is nearly three times higher in patients without full BPD diagnosis compared to those meeting full criteria (0.23 versus 0.08) 2.
This means your patient with 5 borderline features likely experiences:
- Measurable psychosocial impairment
- Increased risk for other psychiatric comorbidities
- Greater subjective distress than individuals without borderline features
- Potential for progression to full-threshold BPD
Recommended Clinical Actions
You should proceed with a comprehensive diagnostic interview using a structured tool such as the Diagnostic Interview for DSM-IV Personality Disorders (DIPD-IV) or the Structured Clinical Interview for DSM (SCID-II) to determine:
- Which specific DSM-5 BPD criteria are present
- Severity and functional impairment from these features
- Presence of comorbid conditions (depression, anxiety, substance use)
- History of self-directed violence or suicidal ideation
Assessment Priorities
Evaluate specifically for:
- Affective instability and emotional dysregulation
- Interpersonal dysfunction in relationships
- Identity disturbance and sense of self
- Impulsivity in potentially self-damaging areas
- Self-harm behaviors or suicidal ideation (requires immediate safety assessment)
- Chronic feelings of emptiness
- Anger management problems
- Stress-related paranoia or dissociation
Treatment Considerations
Even at subthreshold levels, evidence-based interventions can prevent progression and reduce morbidity:
Dialectical Behavior Therapy (DBT) is the gold-standard psychotherapy, originally developed for BPD, combining CBT with skills training in emotion regulation, interpersonal effectiveness, and distress tolerance 3. DBT reduces self-directed violence and improves functioning even in subthreshold presentations.
Cognitive Behavioral Therapy (CBT) reduces suicidal ideation, hopelessness, and problematic thinking patterns, typically requiring fewer than 12 sessions 3.
Pharmacotherapy has a limited role—no medications are FDA-approved specifically for BPD, but may target comorbid symptoms like depression or anxiety if present [@1-10@].
Critical Caveats
- The MSI-BPD is a screening tool only, not a diagnostic instrument 4. A positive screen requires diagnostic confirmation.
- Diagnostic accuracy varies across populations—consider cultural factors and age (sensitivity increases to 90% and specificity to 93% in patients ≤25 years old) 1.
- Subthreshold BPD still carries significant morbidity risk and should not be dismissed as clinically insignificant 2.
- Screen for suicide risk immediately if any self-harm history or current ideation is present, as BPD populations have heightened risk for self-directed violence 3.
The score indicates your patient has meaningful borderline personality features requiring clinical attention, even though they don't meet full diagnostic criteria for BPD at this time.